Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P de Moerloose

Showing results (21-30 of 269) with videos related to

Pageof 27
Sort By:
Revue Medicale De La Suisse Romande|August 26, 1998
[Anticoagulants and platelet antiaggregants: lessons of the last 20 years]P De Moerloose, F Boehlen
Seminars in Thrombosis and Hemostasis|January 5, 2001
D-dimer assays for the exclusion of venous thromboembolismG Reber, P de Moerloose
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 20, 2016
Management of congenital quantitative fibrinogen disorders: a Delphi consensusA Casini, P de Moerloose,
Journal of Thrombosis and Haemostasis : JTH|April 23, 2004
Is laboratory monitoring of low-molecular-weight heparin therapy necessary? NoH Bounameaux, P de Moerloose
Journal of Pharmaceutical Sciences|November 1, 1972
Column chromatographic determination of polymyxin B sulfateA Haemers, P De Moerloose
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1976
[Fluorescence quenching of sodium-1,2-naphthoquinonesulfonic acid by primary amines]P de Moerloose, W Baeyens
Seminars in Thrombosis and Hemostasis|October 23, 2001
How and when to monitor a patient treated with low molecular weight heparinB Boneu, P de Moerloose
Revue Medicale Suisse|November 29, 2012
[New anticoagulants: better knowledge, better prescriptions]F Boehlen, P de Moerloose
Journal of Chromatography|October 7, 1970
The identification of polymyxin B sulphateA Haemers, P De Moerloose
Critical Reviews in Oncology/Hematology|August 10, 1999
von Willebrand factor: from cell biology to the clinical management of von Willebrand's diseaseU M Vischer, P de Moerloose
Pageof 27

Showing results (21-30 of 269) with videos related to

Sort By:
Pageof 27
Revue Medicale De La Suisse Romande|August 26, 1998
[Anticoagulants and platelet antiaggregants: lessons of the last 20 years]P De Moerloose, F Boehlen
Seminars in Thrombosis and Hemostasis|January 5, 2001
D-dimer assays for the exclusion of venous thromboembolismG Reber, P de Moerloose
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 20, 2016
Management of congenital quantitative fibrinogen disorders: a Delphi consensusA Casini, P de Moerloose,
Journal of Thrombosis and Haemostasis : JTH|April 23, 2004
Is laboratory monitoring of low-molecular-weight heparin therapy necessary? NoH Bounameaux, P de Moerloose
Journal of Pharmaceutical Sciences|November 1, 1972
Column chromatographic determination of polymyxin B sulfateA Haemers, P De Moerloose
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1976
[Fluorescence quenching of sodium-1,2-naphthoquinonesulfonic acid by primary amines]P de Moerloose, W Baeyens
Seminars in Thrombosis and Hemostasis|October 23, 2001
How and when to monitor a patient treated with low molecular weight heparinB Boneu, P de Moerloose
Revue Medicale Suisse|November 29, 2012
[New anticoagulants: better knowledge, better prescriptions]F Boehlen, P de Moerloose
Journal of Chromatography|October 7, 1970
The identification of polymyxin B sulphateA Haemers, P De Moerloose
Critical Reviews in Oncology/Hematology|August 10, 1999
von Willebrand factor: from cell biology to the clinical management of von Willebrand's diseaseU M Vischer, P de Moerloose
Pageof 27